James E. Flynn - Director, * Director by Deputization, 10%+ Owner at Larimar Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, * Director by Deputization, 10%+ Owner
Stock Symbol
LRMR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

James E. Flynn - trading volume in the past year for Larimar Therapeutics, Inc.

Holdings reported by James E. Flynn for Larimar Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 9.54M $30.5M $3.20 Jul 31, 2025 Through Deerfield Private Design Fund IV, L.P.
Common Stock 9.54M $30.5M $3.20 Jul 31, 2025 Through Deerfield Private Design Fund III, L.P.
Common Stock 7.32M $23.4M $3.20 Jul 31, 2025 Through Deerfield Healthcare Innovations Fund, L.P.
Common Stock 4.21M $11.3M $2.69 Jul 31, 2025 Through Deerfield Partners, L.P.
Stock Option (Right to Buy) 19K May 13, 2025 Through Deerfield Management Company, L.P. Common Stock

Transactions reported by James E. Flynn for Larimar Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.